| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Goat |
| Applications | ELISA,WB-Ti |
| Brand: | Abnova |
| Reference: | PAB6720 |
| Product name: | CACNB4 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of CACNB4. |
| Gene id: | 785 |
| Gene name: | CACNB4 |
| Gene alias: | CAB4|CACNLB4|EA5|EJM |
| Gene description: | calcium channel, voltage-dependent, beta 4 subunit |
| Immunogen: | A synthetic peptide corresponding to human CACNB4. |
| Immunogen sequence/protein sequence: | CSPGGYSHDSRHRL |
| Protein accession: | NP_001005747.1;NP_000717.2;NP_001005746.1 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:8000) Western Blot (0.3-1 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Specificity: | This antibody is expected to recognize all reported protein isoforms of human CACNB4 (NP_001005747.1, NP_000717.2, NP_001005746.1, ). |
| Reactivity: | Human |
| Application image: | ![]() |
| Application image note: | CACNB4 polyclonal antibody (Cat # PAB6720) (0.2 ug/mL) staining of human bone marrow lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
| Applications: | ELISA,WB-Ti |
| Shipping condition: | Dry Ice |
| Publications: | Requirement of voltage-gated calcium channel beta4 subunit for T lymphocyte functions.Badou A, Basavappa S, Desai R, Peng YQ, Matza D, Mehal WZ, Kaczmarek LK, Boulpaep EL, Flavell RA. Science. 2005 Jan 7;307(5706):117-21. |